Statement Of Financial Position [Abstract]

ERYTECH Pharma S.A. - Filing #858938

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	393,000 EUR	—	—	—	—	—	—	18 960 EUR	—	—	—	—	—	—	—	—	—	20 862 EUR	—	—	—	—	—	—
Intangible assets other than goodwill	5,000 EUR	—	—	—	—	—	—	15,000 EUR	—	—	—	—	—	—	—	—	—	589,000 EUR	—	—	—	—	—	—
Cash and cash equivalents	38 789 EUR	—	—	—	—	—	—	33 699 EUR	—	—	—	—	—	—	—	—	—	44 446 EUR	—	—	—	73 173 EUR	—	—
Assets	45 811 EUR	—	—	—	—	—	—	66 768 EUR	—	—	—	—	—	—	—	—	—	80 402 EUR	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	3 102 EUR	—	—	—	—	—	—	3 102 EUR	—	—	—	—	—	—	—	—	—	2 006 EUR	—	—	—	—	—	—
Share premium	48 975 EUR	—	—	—	—	—	—	97 618 EUR	—	—	—	—	—	—	—	—	—	120 705 EUR	—	—	—	—	—	—
Equity attributable to owners of parent	23 487 EUR	29 765 EUR	228,000 EUR	48 975 EUR	3 102 EUR	1 402 EUR	53 797 EUR	22 845 EUR	25 293 EUR	97 618 EUR	1 215 EUR	3 102 EUR	2 006 EUR	1 744 EUR	73 300 EUR	24 616 EUR	120 705 EUR	26 539 EUR	1 344 EUR	281 688 EUR	62 659 EUR	85 560 EUR	136 607 EUR	1 794 EUR
Liabilities [abstract]
Deferred tax liabilities	— EUR	—	—	—	—	—	—	— EUR	—	—	—	—	—	—	—	—	—	— EUR	—	—	—	—	—	—
Equity and liabilities	45 811 EUR	—	—	—	—	—	—	66 768 EUR	—	—	—	—	—	—	—	—	—	80 402 EUR	—	—	—	—	—	—